Navigation Links
NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record
Date:2/2/2012

now have the three main settings of care – the hospital, the ED, and the physician's office – connected on the same vendor platform so our providers will always have access to the most critical patient information," said Randy Davis, Senior Vice President and Chief Information Officer of NorthCrest. "Sunrise also has the built-in analytics we need to monitor and improve our quality performance as we prepare for value-based reimbursement."

Sunrise Clinical Manager provides state-of-the-art Computerized Provider Order Entry (CPOE) as well as integrated pharmacy, knowledge-based medication administration, patient portal and acute and critical care solutions. To help monitor clinical performance and improve patient outcomes across its facilities, NorthCrest will deploy Sunrise Clinical Analytics, a powerful business intelligence and data mining tool. Sunrise Clinical Analytics also provides Meaningful Use certified quality reporting technology that is expected to help NorthCrest satisfy the Stage 2 and Stage 3 requirements of the federal HITECH Act. The hospital achieved Stage 1 attestation in October, 2011, using Allscripts ED.    

Angie Beard, MSN, RN, CCRN, the hospital's Vice President and Chief Nursing Officer, said it was Allscripts ease of use and strong focus on enhancing patient safety that convinced NorthCrest's nurses to embrace the solution.

"When we were weighing Allscripts against other vendors, our nurses were ecstatic to discover there wasn't a single thing we wanted that Sunrise couldn't demonstrate with live functionality," said Beard.  "We believe it will increase our nurse's efficiency while improving employee satisfaction and giving us more care time with our patients because it's so easy and fast to use."

George Dahir, M.D., orthopaedic surgeon at NorthCre
'/>"/>

SOURCE Allscripts Healthcare Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... YORK , April 27, 2015 Harwood ... against the board of directors of Aerie Pharmaceuticals, Inc. ... whether the board has breached its fiduciary duties to ... issued a press release announcing results from its first ... the press release disclosed that in the trial, Rhopressa ...
(Date:4/27/2015)... YORK , April 27, 2015 Bronstein, ... behalf of purchasers of the securities of Celladon Corporation ... are advised to contact Peretz Bronstein or ... info@bgandg.com or 212-697-6484. The investigation ... directors have violated Sections 10(b) and 20(a) of the ...
(Date:4/27/2015)... 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced the ... lonafarnib in patients with chronic hepatitis delta viral (HDV) ... enrolled at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With ... which randomized subjects to receive different doses of lonafarnib ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3
... Inc. (Hologic or the Company) (NASDAQ: HOLX ... diagnostics products, medical imaging systems and surgical products dedicated ... the Company will host presentations for members of the ... North America) trade show in Chicago, IL. For more ...
... Ohio, Oct. 27, 2011 Mettler-Toledo International Inc. (NYSE: ... call to discuss the Company,s third-quarter results on Thursday, November ... live webcast of the call, visit www.mt.com/investors on ... available until November 7, 2011. METTLER TOLEDO ...
Cached Medicine Technology:Hologic to Host Investor Presentation at RSNA 2011 2
(Date:4/28/2015)... Santa Cruz, California (PRWEB) April 28, 2015 ... leader in premium, healthy, and convenient nutrition ... expansion of its distribution through United Natural ... distributor of natural, organic and specialty foods ... will now be available to thousands of ...
(Date:4/27/2015)... Churchview Supportive Living, a Gardant affordable ... and Fashion Show from 10:30 a.m. to noon on ... 2626 W. 63rd St. in Chicago, serves low-income older ... to maintain their independence. , “Mothers, grandmothers, godmothers and ... Day Brunch,” said Director of Marketing Elizabeth Clippard. , ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Women may ... from concussion, according to a new study published online ... mild traumatic brain injury (MTBI), is a common medical ... some individuals. , In most cases, patients who ... Ten to 15 percent of MTBI patients will continue ...
(Date:4/27/2015)... 2015 Jesse L. Goodman, M.D., M.P.H., ... Pharmacopeial Convention (USP) at the recently concluded Convention Meeting ... at Georgetown University and the Director of its Center ... As USP President, a volunteer position, Dr. Goodman will ... be a voting member, ex officio, of the Board ...
(Date:4/27/2015)... 27, 2015 Based in the Twin ... one of the few insurance marketing organizations in the ... and asset protection markets as well as employer sponsored ... afforded Secura Consultants the opportunity to consult with disability ... business easier and quicker. , An example of these ...
Breaking Medicine News(10 mins):Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 2Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 3Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2Health News:Women Show Persistent Memory Impairment after Concussion 2Health News:Women Show Persistent Memory Impairment after Concussion 3Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2
... A recent research has found that the asthma epidemic in ... by adults over the past century . ,The study, ... is published this month in Annals of Allergy, Asthma & ... Asthma and Immunology (ACAAI). ,The pervasiveness of asthma ...
... a woman's reproductive history to start hormone therapy? How does ... is the most beneficial form of estrogen? ,These ... University of Wisconsin School of Medicine and Public Health hope ... of its kind, on the effects of estrogen therapy with ...
... tests using gene sequencing is able to help confirm ... the tools for much more accurate and rapid diagnosis. ... 40 inherited and potentially life-threatening disorders that cause enzymes ... to the accumulation of waste products that damage organs ...
... College London refutes the long-standing "runaway" theory on how HIV ... attacking T helper cells, a class of white blood cells ... long been puzzled as to why this process of depletion ... ,According to the "runaway" hypothesis, T cells infected ...
... documented the first case of virgin birth in cartilaginous fish, after ... aquarium, that had only female sharks which had no contact ... of the pup at Omaha's Henry Doorly Zoo, in the US, ... in one of the female sharks in the aquarium. ...
... Club of Calcutta will reach out to more poor people ... ,"All the three healthcare units we have opened in ... set a target to reach out to more number of ... functionary K.N. Gupta told a press conference Tuesday. ...
Cached Medicine News:Health News:Rise in Cigarette Use may Elucidate Asthma Epidemic in Children 2Health News:Effectiveness of Hormone Therapy During Menopause 2Health News:New DNA Tests Advances Treatment of Lysosomal Storage Diseases 2Health News:Study Refutes Theory on HIV's Effect on White Blood Cells 2
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... FISH pharmDx Kit is a direct fluorescence ... quantitatively determine HER2 gene amplification in formalin-fixed, ... is determined from the ratio between the ... the HER2 gene probe (red signals) and ...
... PathVysion is the only HER-2 assessment test ... Administration (FDA) for three claims: prognosis, adriamycin-based ... therapy selection. PathVysion is the only FISH-based ... Herceptin® package insert as an appropriate test ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: